Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Angina pectoris: the lipid profile and clinical practice]

A N Diogo1

  • 1U.T.I.C-Arsénio Cordeiro, Hospital de Santa Maria, Lisboa.

Acta Medica Portuguesa
|April 1, 1997
PubMed
Summary

This study reviews lipid-lowering therapy for coronary artery disease (CAD) prevention, highlighting findings from the 4S, CARE, and West of Scotland studies for secondary and primary prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The variability of the heart rate in the first 24 hours after fibrinolytic therapy in acute myocardial infarct].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·1999
Same author

[Treatment of the acute phase of myocardial infarction with nitrates].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·1993
Same author

[Influence of the use of Swan-Ganz catheter on the mortality from acute myocardial infarction].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·1992
Same author

[A case of rupture of the left ventricle free wall with papillary muscle dysfunction following acute myocardial infarction, operated on successfully].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·1990
Same author

[Thrombolysis in acute myocardial infarct. Experience at Santa Maria's Hospital].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·1989
Same author

[Role of nitrates in the pharmacologic treatment of heart insufficiency].

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·1989

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
  • Lipid-lowering therapies have evolved significantly, impacting CAD management.
  • Recent clinical trials provide critical data on the efficacy of these therapies.

Purpose:

  • To provide a historical overview of lipid-lowering therapy in relation to CAD.
  • To discuss current issues in secondary prevention of CAD based on recent studies.
  • To examine primary prevention strategies for CAD in light of new evidence.

Summary:

  • The 4S (Scandinavian Simvastatin Survival Study) and CARE (Cholesterol and Recurrent Events) trials demonstrated significant benefits of statin therapy in secondary CAD prevention.
  • The West of Scotland Study provided insights into the role of lipid-lowering therapy in primary prevention of CAD.
  • Current evidence supports the use of lipid-lowering agents for both preventing initial CAD events and reducing recurrence.

Impact:

  • This review synthesizes key findings from landmark trials, informing clinical practice guidelines.
  • It emphasizes the importance of evidence-based lipid management for improving cardiovascular outcomes.
  • The discussion aids healthcare professionals in optimizing therapeutic strategies for CAD prevention.

Related Experiment Videos